US Patent Issued to ABALOS THERAPEUTICS on Sept. 9 for "Administering a lymphocytic choriomeningtitis virus (LCMV) with improved tumor regression properties" (American, German Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,217, issued on Sept. 9, was assigned to ABALOS THERAPEUTICS GMBH (Duesseldorf, Germany).

"Administering a lymphocytic choriomeningtitis virus (LCMV) with improved tumor regression properties" was invented by Karl Sebastian Lang (Essen, Germany) and Halime Kalkavan (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to arenaviruses for use in the treatment and/or prevention of tumors and also a method for preparing arenaviruses with (improved) tumor-regressive properties."

The patent was filed on Oct. 30, 2023, under Application No. 18/385,250.

*For further information, including images, charts and tables, please v...